LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

Search

Simulations Plus Inc

Отворен

СекторЗдравеопазване

14.91 1.64

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

14.38

Максимум

14.8

Ключови измерители

By Trading Economics

Приходи

-70M

-67M

Продажби

-2.1M

20M

P/E

Средно за сектора

48.528

35.664

Дивидентна доходност

0.48

Марж на печалбата

-330.585

Служители

243

EBITDA

-79M

-74M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+72% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.48%

3.12%

Следващи печалби

22.10.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-66M

285M

Предишно отваряне

13.27

Предишно затваряне

14.91

Настроения в новините

By Acuity

31%

69%

99 / 371 Класиране в Healthcare

Simulations Plus Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.09.2025 г., 22:39 ч. UTC

Придобивния, сливания и поглъщания

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15.09.2025 г., 16:43 ч. UTC

Значими двигатели на пазара

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15.09.2025 г., 16:42 ч. UTC

Значими двигатели на пазара

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15.09.2025 г., 16:35 ч. UTC

Значими двигатели на пазара

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15.09.2025 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.09.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15.09.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15.09.2025 г., 22:48 ч. UTC

Пазарно говорене

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15.09.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

CSL Expects Commercial Launch in 2029

15.09.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15.09.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15.09.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

CSL to Have Right to Exercise Option Based on Phase 3 Data

15.09.2025 г., 22:10 ч. UTC

Придобивния, сливания и поглъщания

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15.09.2025 г., 21:16 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15.09.2025 г., 21:16 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15.09.2025 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15.09.2025 г., 21:14 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.09.2025 г., 19:29 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15.09.2025 г., 19:14 ч. UTC

Пазарно говорене

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15.09.2025 г., 18:16 ч. UTC

Пазарно говорене

Gold Powers to New High -- Market Talk

15.09.2025 г., 18:05 ч. UTC

Пазарно говорене

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15.09.2025 г., 17:50 ч. UTC

Придобивния, сливания и поглъщания

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15.09.2025 г., 17:10 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.09.2025 г., 17:10 ч. UTC

Пазарно говорене

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15.09.2025 г., 16:52 ч. UTC

Пазарно говорене

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15.09.2025 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.09.2025 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Simulations Plus Inc Прогноза

Ценова цел

By TipRanks

72% нагоре

12-месечна прогноза

Среден 25.25 USD  72%

Висок 31 USD

Нисък 20 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Simulations Plus Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

4

Купи

2

Задържане

0

Продай

Настроение

By Acuity

99 / 371 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat